Log in or Sign up for Free to view tailored content for your specialty!
Regulatory/Legislative News
Caution: Do not hold on to Medicare overpayments

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.
Report calls for transformation of eye and vision health initiatives
Nearly 16 million Americans are living with vision impairment that is undiagnosed or untreated because eye and vision health lags in priority in the United States, according to a new report from the National Academies of Sciences, Engineering, and Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Doubts cast on validity of regulations
COPENHAGEN — At Euretina 2016, José Carlos Pastor, MD, talks about the case of cytotoxic batches of a perfluorocarbon liquid that led to blindness in 117 patients in Spain last year. The case casts doubts on the validity of regulations and international standards for the testing of medical devices.
FDA adds ocular indication for Humira, issues complete response letters
Recent FDA activity includes the addition of an ocular indication for AbbVie’s Humira and the issuance of two complete response letters, one to Ocular Therapeutix and one to Valeant, citing manufacturing concerns. Ocular Surgery News compiled these stories from Healio.com/OSN.
Proposed legislation may provide some relief for frustrated physicians

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.
Physician responsibilities for suspected Medicare overpayments

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.
July’s top five FDA news stories in ophthalmology
July’s hot topics in ophthalmology ranged from long-awaited FDA approvals including Shire’s lifitegrast ophthalmic solution for dry eye disease to Allergan’s de novo application submission to the FDA for the Oculeve intranasal tear neurostimulator.
President Obama outlines progress, future of Affordable Care Act

The United States "will be better off" due to the progress that the Affordable Care Act has made in addressing inadequacies in the health care system, according to a special communication issued by President Barack Obama, JD.
Brexit creates concerns among young ophthalmologists

OVIEDO, Spain — The U.K.’s decision to leave the European Union created shock and concern among the attendees of the European Meeting of Young Ophthalmologists.
VIDEO: Speaker shares views on generic glaucoma medications
PRAGUE — At the European Glaucoma Society Congress, Anton Hommer, MD, expresses the importance of prescribing glaucoma patients brand name glaucoma medications.
-
Headline News
This month on Community: Mobile app, mentoring, Book Club happenings
March 12, 20252 min read -
Headline News
OB/GYNs more comfortable with penicillin allergy delabeling vs. allergists, survey shows
March 13, 20252 min read -
Headline News
Treating sleep apnea deemed important by US adults but 31% not receiving treatment
March 12, 20256 min read
-
Headline News
This month on Community: Mobile app, mentoring, Book Club happenings
March 12, 20252 min read -
Headline News
OB/GYNs more comfortable with penicillin allergy delabeling vs. allergists, survey shows
March 13, 20252 min read -
Headline News
Treating sleep apnea deemed important by US adults but 31% not receiving treatment
March 12, 20256 min read